Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0V7HJ
|
||||
| Former ID |
DNC006797
|
||||
| Drug Name |
3-[2-(N,N,N-trimethylammonium)ethoxy]pyridine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528245] | ||
| Formula |
C10H17N2O+
|
||||
| Canonical SMILES |
C[N+](C)(C)CCOC1=CN=CC=C1
|
||||
| InChI |
1S/C10H17N2O/c1-12(2,3)7-8-13-10-5-4-6-11-9-10/h4-6,9H,7-8H2,1-3H3/q+1
|
||||
| InChIKey |
WBRKKKJHXQZXEM-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuronal acetylcholine receptor protein, beta-2 chain | Target Info | Inhibitor | [528245] | |
| Neuronal acetylcholine receptor protein, alpha-4 chain | Target Info | Inhibitor | [528245] | ||
| Reactome | Highly sodium permeable acetylcholine nicotinic receptors | ||||
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | |||||
| Highly calcium permeable nicotinic acetylcholine receptorsR-HSA-629587:Highly sodium permeable acetylcholine nicotinic receptors | |||||
| Highly calcium permeable nicotinic acetylcholine receptors | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.